Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.

Garcia, V D; Bonamigo-Filho, J S; Neumann, J; Fogliatto, L; Gaiger, A M; Garcia, C D; Barros, V; Keitel, E; Bittar, A E; Santos, A F; Roithmann, S

Garcia, V D; Bonamigo-Filho, J S; Neumann, J; Fogliatto, L; Gaiger, A M; Garcia, C D; Barros, V; Keitel, E; Bittar, A E; Santos, A F; Roithmann, S.

Affiliation

Garcia VD; Fundação Faculdade Federal de Ciências Médicas and Santa Casa Hospital, Porto Alegre, Brazil.

Transplant Proc ; 34(7): 2993-5, 2002 Nov.

Article in En | MEDLINE | ID: mdl-12431680

Subject(s)

Antibodies, Monoclonal/therapeutic use; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/adverse effects; Lymphoproliferative Disorders/drug therapy; Postoperative Complications/drug therapy; Sirolimus/therapeutic use; Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Humans; Male; Rituximab

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Kidney Transplantation / Sirolimus / Immunosuppressive Agents / Lymphoproliferative Disorders / Antibodies, Monoclonal Limits: Adolescent / Adult / Humans / Male Language: En Journal: Transplant Proc Year: 2002 Type: Article Affiliation country: Brazil

Search on Google

XML

PubMed Links